Greenvale Raises AUD 856K at $0.044 Per Share with Free Options Attached
Greenvale Energy has raised approximately AUD 856,000 through an oversubscribed Share Purchase Plan, strengthening its uranium exploration efforts in Queensland and the Northern Territory.
- SPP raised AUD 856,000, exceeding AUD 500,000 target
- New shares priced at $0.044 with free attaching options
- Funds to support Oasis Uranium Project and NT field campaigns
- General Meeting planned to approve option issuance
- Company optimistic on uranium sector growth and strategic M&A
Capital Raise Surpasses Expectations
Greenvale Energy Limited (ASX, GRV) has successfully closed its Share Purchase Plan (SPP), attracting firm applications totaling around AUD 856,000, well above the initial AUD 500,000 target. This oversubscription reflects strong shareholder confidence in the company’s uranium exploration strategy and growth prospects.
The SPP issued approximately 19.45 million new shares at $0.044 each, with a compelling incentive of free attaching unlisted options on a 1, 2 basis. These options carry an exercise price of $0.07 and expire on 30 November 2026, offering shareholders potential upside if the company’s exploration efforts bear fruit.
Funding the Next Phase of Exploration
The proceeds from the SPP, combined with a recent placement, bring Greenvale’s available funds close to AUD 1 million. These resources are earmarked for advancing uranium exploration, particularly at the Oasis Uranium Project in Queensland, where recent drilling and trenching programs have been completed. The company is currently awaiting final assay results, which will be critical in shaping the next stage of fieldwork.
Looking ahead, Greenvale plans to deploy exploration teams back into the field in the first quarter of 2026, not only at Oasis but also across its promising Northern Territory portfolio. This continued investment underscores the company’s commitment to expanding its resource base amid a uranium market that is gaining momentum globally.
Governance and Strategic Outlook
Greenvale will convene a General Meeting in early January 2026 to seek shareholder approval for issuing the options attached to the SPP and the recent placement. The outcome of this meeting will be closely watched as it affects the company’s capital structure and shareholder dilution.
CEO Alex Cheeseman highlighted the positive sector dynamics, noting that the uranium industry is experiencing strong tailwinds. He emphasized that sustained exploration and resource growth remain the best path to long-term shareholder value. Additionally, the company is actively evaluating strategic mergers and acquisitions to complement its organic growth.
Sector Context and Market Implications
Uranium’s role in the global energy transition is increasingly recognised, with demand forecasts rising amid nuclear energy’s low-carbon credentials. Greenvale’s bolstered funding positions it well to capitalise on this trend, but the market will be attentive to upcoming assay results and the company’s ability to convert exploration success into tangible resource upgrades.
Bottom Line?
Greenvale’s capital raise sets the stage for a pivotal year in uranium exploration, with upcoming assay results and strategic moves likely to shape its trajectory.
Questions in the middle?
- What will the upcoming assay results reveal about the Oasis Uranium Project’s potential?
- How will the General Meeting’s approval of options impact shareholder value and dilution?
- What strategic M&A opportunities is Greenvale considering to accelerate growth?
